J B Chemicals & Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.48

15.46

15.46

15.46

16.05

Share application money

121.62

62.65

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

2,305.38

2,025.56

1,791.00

1,429.83

1,468.52

Loan funds

Secured loans

526.93

26.32

26.43

32.04

25.80

Unsecured loans

-

-

-

-

-

Total

2,969.41

2,129.98

1,832.89

1,477.33

1,510.36

Uses of funds

Fixed assets

Gross block

2,444.24

1,773.44

1,097.48

1,094.50

1,001.48

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

622.58

569.77

532.88

511.29

449.37

Net block

1,821.66

1,203.67

564.60

583.21

552.11

Capital work-in-progress

55.15

18.68

25.57

16.17

15.09

Investments

338.94

145.69

810.85

536.23

589.49

Net current assets

Current assets, loans & advances

1,254.40

1,170.04

799.41

675.41

635.42

Less : current liabilities & provisions

500.74

408.08

367.54

333.69

281.76

Total net current assets

753.66

761.95

431.87

341.72

353.67

Miscellaneous expenses not written

-

-

-

-

-

Total

2,969.41

2,129.98

1,832.89

1,477.33

1,510.36

Notes:

Book value of unquoted investments

146.75

145.69

145.88

145.85

145.00

Market value of quoted investments

-

-

664.97

390.38

444.49

Contingent liabilities

120.63

68.13

117.00

121.66

86.45

Number of equity sharesoutstanding (Lacs)

773.78

772.82

772.82

772.82

802.37